LMA MAD Nasal Mucosal Atomization Device

When intravenous access is difficult, delayed, or simply not available, the LMA MAD Nasal delivers medication through the nasal mucosa — a route that puts fast-absorbing drugs to work without a needle. This collection features the LMA MAD300 Intranasal Mucosal Atomization Device, the compact 1.65-inch model with a 0.17-inch tip designed to fit standard luer syringes and produce a fine, controlled mist across the nasal turbinates.

Atomization matters because a fine particle spray covers far more mucosal surface area than drops or a stream, which pool and run off. That broader distribution supports quicker, more reliable uptake of medications such as naloxone, midazolam, fentanyl, and other emergency and sedation drugs administered intranasally. For EMS crews, emergency departments, and pediatric providers, that translates to a needle-free option that reduces exposure risk and calms an anxious patient.

A few practical points buyers ask about: the MAD300 ships without a syringe, so you'll pair it with the luer-slip or luer-lock syringe your protocol specifies. Effective use typically calls for a small priming volume to fill the device's dead space, and dividing the dose between both nostrils improves absorption. It's a single-patient, disposable device — clean, consistent atomization every time without reprocessing concerns.

If you're building or restocking an airway and delivery kit, it's worth reviewing adjacent supplies. Explore Oral & Nasal Airways for airway management, Nasal Spray products for other intranasal applications, and Nasal Cannulas for oxygen delivery. The LMA MAD Nasal fits naturally alongside these as part of a complete nasal and airway toolkit.